- Report
- March 2024
- 200 Pages
Global
From €3712EUR$4,150USD£3,181GBP
- Report
- July 2024
- 150 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4249EUR$4,750USD£3,641GBP
- Report
- February 2024
- 126 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Report
- May 2025
- 300 Pages
Global
From €4427EUR$4,949USD£3,793GBP
- Report
- July 2025
- 200 Pages
India
From €2495EUR$2,789USD£2,138GBP
- Report
- August 2026
- 70 Pages
Australia
From €4249EUR$4,750USD£3,641GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4249EUR$4,750USD£3,641GBP
- Report
- February 2024
- 75 Pages
Canada
From €4249EUR$4,750USD£3,641GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4249EUR$4,750USD£3,641GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4249EUR$4,750USD£3,641GBP
- Report
- September 2025
- 189 Pages
Global
From €4026EUR$4,500USD£3,449GBP
- Report
- May 2024
- 129 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- May 2024
- 140 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- August 2026
- 70 Pages
Egypt
From €4249EUR$4,750USD£3,641GBP
- Report
- June 2025
- 400 Pages
Global
From €4427EUR$4,949USD£3,793GBP
- Report
- July 2023
- 160 Pages
Global
From €4427EUR$4,949USD£3,793GBP
- Report
- December 2024
- 144 Pages
Global
From €13414EUR$14,995USD£11,493GBP
- Report
- August 2025
- 150 Pages
Global
From €2827EUR$3,160USD£2,422GBP
€3534EUR$3,950USD£3,027GBP

The Smart Insulin market is a subset of the larger Diabetes Devices market. It is composed of products that are designed to help people with diabetes better manage their condition. Smart Insulin products are designed to automatically adjust the amount of insulin delivered to the body based on the user's blood sugar levels. This helps to reduce the risk of hypoglycemia and other complications associated with diabetes. Smart Insulin products are typically connected to a smartphone or other device, allowing users to monitor their blood sugar levels and adjust their insulin dosage accordingly.
The Smart Insulin market is growing rapidly, driven by the increasing prevalence of diabetes and the need for better management of the condition. The market is expected to continue to grow in the coming years, as more people are diagnosed with diabetes and the need for better management of the condition increases.
Some companies in the Smart Insulin market include Bigfoot Biomedical, Beta Bionics, Companion Medical, and Senseonics. Show Less Read more